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Objectives: We investigated the management of staphylococcal abscesses (boils) by
general practitioners (GPs) in the context of rising antibiotic resistance in community
strains of Staphylococcus aureus.
Design, Setting, Participants: We analyzed patient-reported management of 66
cases of uncomplicated skin abscesses from the frequency matched methicillin-
resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) Community-
Onset Staphylococcus aureus Household Cohort (COSAHC) study (Melbourne,
Australia, 2008–2012). Susceptibilities in all cases were known: 50/66 abscesses were
caused by MRSA. In order to investigate GP-reported management of staphylococcal
abscesses, we surveyed a random subset of GPs, from the COSAHC study (41), and
of GPs (39) who used the same community-based pathology service (December 2011–
May 2012).
Main outcome measures: Patient outcomes, antibiotics prescribed, antibiotic
resistance profiles of infecting strains, rates of incision and drainage (I&D), and attitudes
to ordering microbiological cultures.
Results: MRSA was three times more likely to be cultured from an abscess than
MSSA. Patient-reported management revealed 100% were prescribed antibiotics and
only 60.6% had I&D. Of those 85% who remembered their prescription(s), 81% of MRSA
cases and 23% of MSSA cases initially received inactive antibiotics. Repeat GP visits
where antibiotics were changed occurred in 45 MRSA and 7 MSSA cases, although at
least 33% of subsequent prescriptions were inactive for the MRSA infections.
Patients treated with I&D and antibiotics did no better than those treated with only I&D,
regardless of the antibiotic activity. In the GP surveys, 89% reported I&D, with or without
antibiotics, to be their preferred management. Only 29.9% of GPs would routinely swab
abscesses.
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Conclusion: The recommended management of uncomplicated Staphylococcus
abscesses is I&D without antibiotics to reduce exposure to unnecessary antibiotics. In
our study, I&D was performed in only 60.6% of 66 patients, and antibiotics were always
prescribed. The prescribed antibiotics were frequently inactive and often changed, and
did not appear to affect patient recovery. Our results show that community GPs can
confidently reduce their use of antibiotics for patients with skin abscesses and should
be aware that MRSA is a much more common in this type of infection.
Keywords: antibiotic resistance, Staphylococcus aureus, skin and soft tissue infections, community medicine,
boils and abscesses
INTRODUCTION
Little is known about Australian general practitioners’ (GPs)
management protocols in practice for skin abscesses and how
this might be evolving with the changing epidemiology of
Staphylococcus aureus. Australian Therapeutic Guidelines:
Antibiotic (version 15; Antibiotic Expert Groups, 2014)
recommends uncomplicated abscesses should be managed with
incision and drainage (I&D) alone – without antibiotics. Previous
guidelines (Dermatology Expert Groups, 2009) available to GPs
at the time of our study, also recommended only I&D for
abscesses <5 cm. Antibiotics were only recommended if there
was associated spreading cellulitis or systemic symptoms.
After a 2011 review, clinical practice guidelines from the
Infectious Diseases Society of America (IDSA) continued
to recommend I&D; specifically, that effective treatment
requires incision, thorough evacuation of pus, and probing
the cavity to break up loculations (Liu et al., 2011; Moran
et al., 2013). IDSA practice guidelines are similar to the
Australian Therapeutic Guidelines for primary treatment
(CDC, AMA, IDSA, 2007; Lowy et al., 2008; Liu et al.,
2011; Centers for Disease Control and Prevention [CDC],
2013; Moran et al., 2013). However, they differ in their
recommended first line antibiotics in cases where antibiotics
are indicated, due to higher rates of community-acquired
MRSA (CA-MRSA) in the United States. The IDSA guidelines
recommend clindamycin, trimethoprim-sulfamethoxazole,
a tetracycline (doxycycline/minocycline) and linezolid (Liu
et al., 2011). In contrast, the recommended antibiotics for
complicated abscesses in the Australian Therapeutic Guidelines
are di/flucloxacillin or, in penicillin-allergic patients, cephalexin.
In penicillin hypersensitive patients, the recommendation is to
use clindamycin or trimethoprim-sulfamethoxazole. Antibiotics
are to be modified based on culture results (Antibiotic Expert
Groups, 2014).
We have calculated that in 2006, 3–5% of patients presenting
with community-onset S. aureus infections in Melbourne had an
MRSA infection (Bennett et al., 2014). The preliminary findings
of the COSAHC study suggest this has risen to 8–10% by 2010,
and may be higher again when aggressive pyogenic soft tissue
S. aureus infections have been investigated, showing MRSA the
more likely causative organism (Jahamy et al., 2008; del Giudice
et al., 2009; Coombs et al., 2014). This study will show that CA-
MRSA is three times more likely than MSSA to be the cultured
organism in skin abscesses.
With CA-MRSA increasing in prevalence in Australia and
elsewhere, there may be an argument for all lesions to be swabbed
for microbiological culture and sensitivity (MC&S), not only
to tailor treatment (as in complicated infections) but also for
MRSA surveillance (CDC, AMA, IDSA, 2007; Lowy et al., 2008;
Dermatology Expert Groups, 2009; Liu et al., 2011; Centers for
Disease Control and Prevention [CDC], 2013; Antibiotic Expert
Groups, 2014). However, for uncomplicated abscesses, if, as is
recommended, I&D is routinely and correctly used, (thorough
evacuation of pus, and probing the cavity to break up loculations)
and antibiotics are not used, then swabs may have little impact
on individual care (Parnes et al., 2011). Community GPs may
not realize that CA-MRSA is the most likely organism to cause
uncomplicated abscesses. Further over prescription may occur
with the return of a culture and sensitivity report, indicating the
prescribed (unnecessary) antibiotic is inactive, which may drive
an antibiotic change, resulting in even more ineffective antibiotics
as well as unnecessary visits to the GP.
Our study set out to describe the management by community
GPs of staphylococcal skin abscesses so we can better understand
how often I&D is performed, if and what types of antibiotics are
used, and whether antibiotics affect patient recovery. We also
wanted to understand how often and for what reason GPs send
swabs for MC&S.
MATERIALS AND METHODS
Patient Data
Community-Onset Staphylococcus aureus Household Cohort is a
longitudinal cohort study of 291 index patients with community-
onset S. aureus infections, and 446 household contacts. Index
patients were recruited through a large private pathology
provider on the basis of a positive S. aureus MC&S result for their
infection. The pathology provider serves the entire Melbourne
metropolitan area. All eligible patients with community-onset
MRSA infections were invited to participate together with
a frequency-matched subset of eligible patients with MSSA
infections. The COSAHC project was approved by the Deakin
University Human Research Ethics Committee (project number
2009-162).
Shared households (204) were followed up at 3-monthly
intervals for up to 2 years (recruitment period 2008–2011).
At each visit, index patients and household members had
swabs obtained from nares and axillae for S. aureus carriage
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to determine the molecular epidemiology of strains circulating
within households. Questionnaires were completed to provide
information on the medical management and outcome of the
index cases’ infection as well as household interactions, infection
history, new infections and risks for S. aureus transmission and
MRSA carriage.
Of the 291 index patients, 137 had MRSA infections and 154
had MSSA infections. The majority were skin and soft tissue
infections (86.2%), and 66 of the index patients had skin abscesses
(50 MRSA, 16 MSSA) and are included in the present analysis.
We extracted data on the doctor-reported data management
(when remembered) as well as patient-reported management
and outcomes for these 66 skin abscess infections; including
whether I&D was performed or if and what type of antibiotics
were prescribed. We also established the resistance profile of the
infecting strain, and the number of days off normal activities and
timing of infection resolution.
Doctor Survey Data
To understand the clinical decisions behind treatment practices,
we conducted a cross-sectional survey of community GPs on their
management protocols for S. aureus abscesses using a constructed
case study (see below). Participating doctors were from one of
two groups, recruited by telephone and fax from December 2011
to May 2012. The survey tool asked a series of questions on their
treatment of this hypothetical case, and decisions to swab.
Case Study Extract
A patient presents to your clinic with a boil in their right armpit. Over the course
of 3 days, the area has become increasingly reddened, tender and the center is
raised and now forms a pus-filled head. There are no signs of systemic infection
but there is evidence of localized infection. The patient has no other health
problems and is not on any medication.
1. With this history, how would you treat the patient? (Select 1 or more)
(a) No treatment
(b) Incision and drainage (I&D)
(c) I&D and antibiotics
(d) Antibiotics only
(e) Other (please specify)
2. If this boil was weeping or lanced*, would you swab this boil for culture and
if so why?
Followed by a series of multiple choice and open ended questions on
treatment choices and motivators for, and frequency of, collecting swabs.
∗Lanced used interchangeably with incision
Group 1: Doctors Who Ordered the Baseline Tests on
Patients Who Were Recruited to the COSAHC Study
We surveyed a random sample of 41 doctors treating
community-onset S. aureus infections that had previously
been studied in COSAHC. A subset of these doctors had treated
eight COSAHC- patients who had an abscess as their index
infection, allowing us the additional opportunity to directly
compare GP-reported management protocols from the survey to
the real life patient-reported management in these cases.
Group 2: Comparative GP Sample
To determine how representative COSAHC doctors’ patient
management was, we compared their survey responses to those
of a random sample of 39 GPs practicing within metropolitan
Melbourne who had ordered routine blood tests (Full blood
count and Urea and Electrolytes) in the same period from the
same pathology provider.
Both groups of doctors were invited to return a survey tool by
fax or complete over the telephone. The exclusion criteria were
being on leave for more than one month at the time approached
and/or no longer working at the practice. A sample size of 40 per
group was recruited to provide 80% power (α = 0.05) to detect a
30% difference in antibiotic use between GPs.
The survey tool was developed to assess management
protocols and swabbing practice in the context of a short case
study of a patient with an axillary skin abscess. We also asked
participants to provide information on any change to their
practice over the previous three years.
Analysis
Descriptive statistics were applied, including computing
differences between proportions and the associated p-values
and 95% confidence intervals (CIs) using StataSE12. We report
median and inter-quartile range (IQR) for all non-parametric
data.
RESULTS
COSAHC Participants Report of GP
Management of Their Lesion
Abscess management and outcome information was obtained
from the 66 index patients at the first COSAHC household visit.
The susceptibilities of the organisms were known as the patients
were recruited on the basis of a positive S. aureus MC&S result.
The first household visit occurred at an average of 4 months
from the onset of index infection. For the total COSAHC study,
the ratio of MSSA:MRSA in the index patients’ infections was
154:137. Within this abscess subset, the ratio was 16:50. This
indicates that in the setting of an abscess, MRSA is much more
common than background rates in community onset infections.
The average age of the abscess patients was 34.4 years (95% CI
29.3, 39.5), 48% were female (95% CI 37, 60), with an average
household size of 2.7 (95% CI 2.25, 3.14). Nearly half (44% (95%
CI 33, 56)) reported a history of previous skin abscesses. Abscess
site varied (Table 1), however, leg/foot was the most common
(over 30%). Torso (24%) ranked second for MRSA abscesses,
while torso and arm/hand were equal second for MSSA abscesses
(19%).
Abscess management by the GPs, as reported by COSAHC
study patients, are shown in Table 2 with index infections
stratified by methicillin resistance. I&D was performed in 60.6%
of cases, but never in isolation. Antibiotics were prescribed for
100% of cases, however, two patients reported not taking the
antibiotics.
Patient-reported infection resolution is shown in Table 3. Of
those 40 patients who had I&D as part of their treatment, the
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TABLE 1 | Infection sites.
Site of infection MSSA (n = 16)
(%, CI)
MRSA (n = 50)
(%, CI)
Leg/foot 31% (11, 59) 34% (21, 49)
Torso (front/back) 19% (4, 46) 24% (13, 38)
Arm/hand 19% (4, 46) 12% (5, 24)
Axilla 13% (2, 38) 12% (5, 24)
Head/neck 13% (2, 38) 8% (2, 19)
Groin 6% (0.2, 30) 10% (3, 22)
TABLE 2 | Patient-reported GP abscess management by methicillin
resistance (causal organism).
Treatment MSSA (n = 16)
(%, CI)
MRSA (n = 50)
(%, CI)
Total (n = 66)
(%, CI)
I&D and antibiotics 38% (15, 65) 36% (25, 53) 36% (25, 49)
I&D only 0% 0% 0%
Antibiotics only 25% (7, 52) 30% (18, 45) 29% (18, 41)
I&D, antibiotics and other∗ 25% (7, 52) 24% (13, 38) 24% (15, 36)
Antibiotics and other∗ 13% (2, 38) 10% (3, 22) 11% (4, 21)
∗Other treatments include: abscess burst on its own, dressings, hospital admission,
IV antibiotics, syringing, topical creams (non-antibiotic or unspecified), and surgical
removal.
infection resolved by the first home visit in 85% of cases, (95% CI
70, 94). Where I&D was not used (26) the infection was resolved
in 73% of cases (95% CI 52, 88) by the first visit.
Analysis of Antibiotic Use
The antibiotics prescribed were not known for all patients,
meaning the patient could recall the actual name of the
antibiotic(s). However, the majority (85%) could remember the
name of at least one of their prescribed antibiotics: 43 patients
with MRSA and 13 patients with MSSA. We analyzed the
antibiotic susceptibility profiles of the clinical isolates and the
activity of the known antibiotics that were prescribed for these
56 patients (Figures 1 and 2). Antibiotics are described as active
when the organism was susceptible to the prescribed antibiotic
and inactive when the organism was resistant.
In total, over the course of their infections, there were 18
prescriptions of known antibiotics given to 13 patients with
MSSA, of which three (16.7%) were inactive. Of the 81 known
antibiotics prescribed for 43 patients with MRSA, 50 (62%) were
FIGURE 1 | Antibiotic susceptibility by prescription (n = 18) for MSSA
infections.
FIGURE 2 | Antibiotic susceptibility by prescription (n = 81) for MRSA
infections.
inactive. Overall, approximately 53.5% of prescribed antibiotics
were inactive: these included penicillin/amoxicillin for both
MSSA and MRSA, and cephalexin, flucloxacillin, augmentin, or
dicloxacillin for MRSA infections.
Prescriptions for MSSA infections were dominated by
penicillin 16.7% and flucloxacillin, dicloxacillin, cephalexin, and
augmentin (66.7%); However, augmentin and penicillin are
not recommended first line of treatment for MSSA infections:
augmentin because of its unnecessarily broad spectrum activity
TABLE 3 | Patient-reported infection resolution by first home visit (by management protocol).
MSSA (N = 16) MRSA (N = 50) Total (N = 66)
Treatment Resolved 95% CI Resolved 95% CI Resolved 95% CI
I&D and antibiotics 5/6 (83%) (36, 100) 15/18 (83%) (59, 96) 20/24 (83%) (63, 95)
I&D only 0 (0%) – 0 (0%) – 0 (0%) –
Antibiotics only 3/4 (75%) (19, 99) 12/15 (80%) (52, 96) 15/19 (79%) (54, 94)
I&D, antibiotics and other∗ 3/4 (75%) (19, 99) 11/12 (92%) (62, 100) 14/16 (88%) (62, 98)
Antibiotics and other∗ 2/2 (100%) (13, 99) 2/5 (40%) (5, 85) 4/7 (57%) (18, 90)
∗Other treatments include: abscess burst on its own, dressings, hospital admission, IV antibiotics, syringing, topical creams (non-antibiotic or unspecified), and surgical
removal.
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and penicillin/amoxicillin because only 5–10% of MSSA are
susceptible (Turnidge et al., 2016).
Antibiotic Changes and Repeat GP Visits
Of the 43 patients with MRSA infections who recalled at least one
of their specific antibiotic(s), 35 (81%) were initially prescribed an
inactive drug. Of these, 23% never received an active antibiotic,
whilst the rest were subsequently prescribed active (58%) or
unknown (19%) antibiotic(s) at follow-up visits. Three (23.1%)
of 13 patients with MSSA who recalled the specific antibiotic(s)
were also prescribed an inactive drug, with one subsequently
prescribed an active antibiotic.
In our study, 56 patients were able to remember a total of 99
antibiotics (an additional 19 were remembered as a prescription
but not by name). Thirty-seven patients (6 with MSSA and 31
with MRSA infections) were prescribed more than one antibiotic
and, of those, thirteen (1 MSSA patients and 12 MRSA) were
prescribed more than two antibiotics. In addition, eight were
prescribed Mupirocin (site of use unspecified but all organisms
susceptible). We presume that for every new antibiotic prescribed
the patients required a repeat visit to their GP for assessment,
although we do not know if the subsequent prescription changes
were due to treatment failure or antibiotic change based on lab
results showing resistance.
GP Surveys of Abscess Management
One hundred and seventy GPs were approached and 81
completed surveys (48%; 41 COSAHC GPs, 39 comparison GP
and one unlabeled form that could not be ascribed to a particular
GP group). The response rate was higher in the COSAHC GP
group (60% compared with 38%). The average number of years
in practice of those participating was 23.1 years. No differences
were found with treatment preferences between the two cohorts
(Table 4).
Overall, GPs report ‘I&D and antibiotics’ as their preferred
management of abscesses (70%), followed by ‘I&D only’ (19%)
and ‘Antibiotics only’ (10%). Some specified I&D included
additions; one would incise with review and another would
prescribe antibiotic cream alongside. Other selections included
‘no initial treatment, but subsequent patient review’ (indicated as
‘other’ in Table 4).
Decision to Swab Wound
When we stratified treatment choices according to the GPs
decision to swab, we found abscess management did not differ
TABLE 4 | Self-reported management practices by doctor group.
Treatment COSAHC GPs 41 Non-COSAHC Total GPs (81)
n (%∗) GPs (39) n (%) n (%)
I&D and antibiotics 29 (71%) 27 (69%) 57 (70%)
I&D 8 (20%) 7 (18%) 15 (19%)
Antibiotics only 3 (7%) 5 (13%) 8 (10%)
Other 1 (2%) 0 (0%) 1 (1%)
∗All percentages are column percentages.
significantly between the two surveyed doctor groups, with 70%
of both groups reporting their preferred management protocols
as ‘I&D and antibiotics.’ This indicates we have not introduced
patient-management bias via the recruitment method used, other
than including a greater proportion of patients treated by GPs
who swab. More COSAHC doctors did indicate they would swab
if the abscess was weeping or incised (76.9% vs. 56.4%; p= 0.049),
but this was not shown to be associated with differences in
patient management, so we pooled the two GP groups for further
analyses.
Overall, a minority (29.9%) of GPs reported that they
would routinely swab abscesses for culture. Doctors reported
they would swab for definitive diagnostic purposes (68.8%)
or for persistent abscesses (97.4%). About half of doctors
(48.6%) report being influenced by abscess size and a perceived
increased risk of systemic infection or spread to adjacent tissues.
When abscess size was identified as important, thresholds of
size varied from >1 cm to >3 cm. Swabbing practice was
not related to treatment choice or the commencement of
antibiotics.
The rise of MRSA in the community was identified as reason
for changing practice (23%). Some doctors report they are now
more likely to wait for results to prescribe antibiotics and choose
to swab based on clinical site and severity of abscess.
COSAHC Patient Management –
GP-Reported Practice versus Actual
Patient-Reported
Eight doctors of COSAHC patients with abscesses also completed
the GP survey. Whilst the numbers are small, it does provide us
the added opportunity of direct comparison between a patient’
reported abscess treatment and their doctor’s survey responses
(Table 5).
None of the eight responded with the recommended first
line treatment for an abscess, regardless of size. Two reported
that they would not perform I&D and would solely prescribe
antibiotics, which corresponds to the patients’ report. The
remaining six doctors who selected ‘I&D and Antibiotics’ in the
survey varied in their actual clinical response – three out of
six (50%) did not perform I&D and only prescribed antibiotics.
Interestingly, two out of six (33%) administered an antibiotic
TABLE 5 | Community GP-reported management for abscesses versus
patient-reported management.
GP survey response Patients’ report of treatment by same GP
Treatment of patient in
case study
Treatment given for abscess
Antibiotics Antibiotics
Antibiotics Antibiotics
I&D and Antibiotics I&D and Antibiotics
I&D and Antibiotics Self I&D, Antibiotics
I&D and Antibiotics I&D attempt, penicillin injection, oral antibiotics
I&D and Antibiotics I&D ×3, antibiotic injection, oral antibiotics
I&D and Antibiotics Antibiotics (I&D of previous boil)
I&D and Antibiotics Antibiotics
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injection as well as oral antibiotics. This is particularly surprising
because there are no intramuscularly injectable antibiotics that
are active against most S. aureus organisms.
DISCUSSION
We live in an era of rising antibiotic resistance. Conservation of
antibiotics is of critical importance, and in response antibiotic
stewardship programs are being progressively implemented.
Antibiotic stewardship originated to address the problems of
antibiotic overuse in hospitals, but is now being extended to
the community as it is increasingly realized most antibiotics for
human use are prescribed and consumed in the community.
Australian GP compliance with clinical guidelines for abscess
treatment has not previously been researched. In the US
the management of community-acquired abscesses have been
investigated both in general practice and in hospital emergency
departments (Odenholt et al., 2002; Daly et al., 2011; Forcade
et al., 2011; Kemper et al., 2011; Parnes et al., 2011; May
et al., 2012; Schmitz et al., 2013). Pre/post intervention studies
in primary care have been conducted to evaluate abscess
management. For example, the IRENE study looked at antibiotic
prescription coverage – pre-intervention cephalosporins were
frequently prescribed (43%), dropping to 18% of prescriptions
post-intervention. In this cohort, 84% of patients received I&D
and antibiotics pre-intervention. Post-intervention, 97% received
antibiotics and I&D, but there was a demonstrated increase
in MRSA susceptible antibiotics. The option to not prescribe
antibiotics was discussed but did not translate into practice (Daly
et al., 2011).
Similarly, in the SNOCAP-USA and DARTnet study (Parnes
et al., 2011), procedure rates for I&D were initially low.
A practical intervention had no significant effect on the number
of I&D completed or for microbiological cultures, but again, did
result in increased use of MRSA-susceptible antibiotics.
STARnet (Forcade et al., 2011) conducted a prospective
community based observational study of suspected MRSA
abscesses. Only 7% of this cohort had I&D alone, while
64% received both antibiotics and I&D. Twenty-eight percent
of the cohort received only antibiotics with trimethoprim-
sulfamethoxazole used frequently as monotherapy. These studies
also demonstrate the reluctance to stop providing antibiotics
alongside I&D, or at all, despite recommendations.
Hospital emergency department research in the US showed
only 17–19% of abscesses were treated with I&D alone and
treatment with antibiotics alone ranged from 4 to 17%, while
a combination of I&D and antibiotics was the most common
practice (66–79.9%; Moran et al., 2006; Talan et al., 2011;
May et al., 2012; Schmitz et al., 2013). A quality improvement
project (Kemper et al., 2011) was conducted amongst American
pediatricians to develop an intervention to increase adherence to
best practice of abscesses; 83% of those interviewed responded
that they could perform I&D, however, 34% stated it was too time
consuming to perform. The challenge exists then to emphasize
the importance of I&D in treating patients with abscesses and
encouraging best practice.
Our study focuses on community-onset abscess infections
where MRSA is over-represented as a deliberate part of our
sampling strategy. The data drawn from the prospective cohort
of community-onset staphylococcal infections (COSAHC)
identified via a private community-based pathology service,
and the cross-sectional survey of doctors ordering tests through
the same pathology service, has provided the opportunity to
explore doctors’ attitudes and practices in the context of the
changing epidemiology of S. aureus in an Australian urban
community.
The antibiotic susceptibility of isolates for all the COSAHC
participants were known and as this was the criteria for entry
into the study. In the COSAHC study, we found that 85%
of community-onset S. aureus infections were skin and soft
tissue infections and in 66 the infection were skin abscesses and
used in this study. In the management of the 66 participants
with abscesses: 100% were prescribed antibiotics but only 60%
had their abscess incised and drained. Contrary to this, a
larger percentage of doctors (75%) surveyed indicated I&D with
antibiotics was their management of choice for community-
acquired abscesses. That is, more community GPs indicated
that I&D with antibiotics was their management of choice than
appeared to perform it.
Furthermore, where the antibiotic was known, the majority
of patients with abscesses caused by MRSA (81%) were initially
prescribed inactive antibiotics, compared with 23% of those with
MSSA. Antibiotics were changed for 37 patients, resulting in
nearly all MSSA (85%), but only 60.5% of MRSA infections ever
being prescribed an active antibiotic. Overall, 53.5% of antibiotic
choices were inactive against the targeted pathogen.
We have previously estimated that about 8% of infections
caused by S. aureus in the community of metropolitan
Melbourne are MRSA (Bennett et al., 2014), but this is
likely to be much higher for abscesses based on our findings
here. Given the proportion of COSAHC community-onset
infections that are abscesses (66/291, 23%), and the high
rate due to MRSA infections (78% compared with 47% of
all infections among the frequency-matched COSAHC index
cases), we estimate the prevalence of MRSA infections might
be as high as 24% (three times higher) in community-onset
infections presenting as abscesses in metropolitan Melbourne
2010–2012.
From our survey we found that only 30% of community
GPs swab for MC&S. Therefore, many doctors would be
unaware of the proportion of antibiotics prescribed that
were ineffective and they are unlikely to modify their
prescribing practice. According to both contemporary and
Australian guidelines, almost all of the prescriptions for
uncomplicated abscesses could be considered unnecessary.
In support of these guidelines, our study showed there was
little difference in infection resolution whether the antibiotics
were active or not. This was true for ‘I&D + antibiotics’
and ‘antibiotics’ alone (p = 0.71), whether the antibiotics
were active (p = 1.0) or inactive (p = 0.84). However, there
was a trend to greater resolution at first household visit
for those patients who had I&D performed, with 85% of
infections resolved (95% CI 70, 94) compared with 73.1% (95%
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CI 52.2, 88.4) of patients who did not have I&D performed.
A 2007 literature review (Hankin and Everett, 2007) also showed
that those patients treated with I&D alone had the same rate of
resolution as those with I&D and antibiotics.
If an antibiotic is prescribed it is usually at first presentation.
The swab will not help in the initial antibiotic prescription
but a MC&S may be useful in the case of treatment failure
and MRSA surveillance. If I&D is performed correctly, our
findings support guidelines and no antibiotics are needed and
can be stopped. Patients’ expectations regarding treatment is a
challenge for GPs. Patient understanding of best practice can
be narrow and limited to their own situation. There is a need
to increase the health literacy of patients and to make them
aware of the population wider risks associated with antibiotic
over prescription.
Although I&D was consistently reported by GPs to be their
preferred treatment option for uncomplicated abscesses, the
COSAHC study observed only 60% of patients with abscesses
were treated with I&D in practice. Furthermore, I&D was always
accompanied by antibiotics. This suggests that whilst there may
be an understanding of the importance of I&D, there may be a
lack of confidence in performing the procedure without antibiotic
cover.
Given the number of antibiotic changes (37 patients requiring
additional antibiotics) and therefore the presumed increased
number of visits to the GP, it is clear that skin abscesses are
difficult to treat and many different antibiotics are used.
Our study has a number of limitations. The response rate
of 48% in the GP survey has the potential for sampling bias.
However, we believe that any selection bias that may have been
introduced would act to favor doctors who are more aware
of community MRSA and therefore more keen to participate.
Therefore, it is possible that these results underestimate the
actual deviation from recommended practice in the wider GP
community. If this were the case, then the true situation regarding
GP practices may be even more removed from therapeutic
practice guidelines than captured here. It would be useful to
conduct a larger study to more comprehensively examine GP
practice, and gain more detailed insight into GPs’ ability to
perform I&D correctly. Incision type, use of pain control,
irrigation, wound cultures, and packing, would inform targeted
strategies (Forcade et al., 2011; Centers for Disease Control and
Prevention [CDC], 2013).
CONCLUSION
Our findings demonstrate many GPs are not following guideline
recommended practice when it comes to treating patients
with staphylococcal skin abscesses. Our findings support the
recommendations in the current antibiotic guidelines that would
act to curb this trend (Antibiotic Expert Groups, 2014). In
particular:
(1) Antibiotics not indicated unless spreading cellulitis with
systemic symptoms.
(2) Perform I&D correctly on all abscesses, even if antibiotic
therapy is considered.
(3) Modify therapy based on clinical response to initial therapy
and the results of cultures and susceptibility testing. If
S. aureus is isolated, and lesion is responding to drainage,
stop any antibiotics, inactive and active. If antibiotics are
necessary: treatment for 5 days is generally sufficient, but a
longer duration of therapy may be required for patients who
are slow to respond or have a more severe infection.
Overall, the doctors we surveyed demonstrated awareness of
the changing epidemiology of S. aureus infections in Melbourne.
This study provides a basis for developing new programs to assist
GPs to better understand and reduce their use of antibiotics,
and potentially the number of return patient visits. There is also
vital need to improve confidence and proficiency or surgical
techniques such as I&D, which are more effective than antibiotics
in such cases.
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